Category: Drug Safety Alerts
-
Syfovre Retinal Vasculitis And Severe Intraocular Inflammation Cases Reported By Ophthalmologists
A July 2023 "Dear Doctor" Letter From Apellis Acknowledges This Developing Syfovre Safety Signal Situation (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis cites current…
-
Eye Drug Syfovre Side Effects: Occlusive Retinal Vasculitis, Eye Inflammation, Vision Loss, And Blindness
American Society of Retinal Specialists (ASRS) July 2023 Warning Letter About Adverse Events Reports Associated With Syfovre (Posted by Tom Lamb at Drug Injury Watch) UPDATE: From this February 28, 2024, Fierce Pharma news report, "Apellis…
-
Ozempic Side Effects: Gallbladder Diseases, Thyroid Cancer, And Suicidal Thoughts
Diabetes and Weight-Loss Drug Ozempic Getting Scrutiny From European Drug Safety Regulator EMA ***See also: Ozempic Severe Gastric Side Effects Include Stomach Paralysis, Gastroparesis, And Intestinal Blockages (Posted by Tom Lamb at Drug Injury Watch)…
-
Trulicity Recall Due to Dose Labeling Error Back in 2021 May Still be Drug Safety Issue Today
Thousands of Trulicity Autoinjector Devices Labeled as 0.75 mg Might Contain 1.5 mg (i.e., a “double-dose”) (Posted by Tom Lamb at Drug Injury Watch) A Trulicity recall back in August – September 2021 by Eli…
-
Prolia – Hypocalcemia Side Effect Safety Signal May Draw Regulatory Action by FDA
"Risk of severe hypocalcemia" in Patients on Dialysis Receiving Osteoporosis Drug Prolia (denosumab) (Posted by Tom Lamb at Drug Injury Watch) The FDA is in the process of evaluating the osteoporosis drug Prolia (denosumab) to…
-
February Recalls of Eye Products Due to Bacterial Contamination Causing Serious Infections
Timeline for EzriCare Artificial Tears, Delsam Pharma’s Artificial Tears, Delsam Pharma’s Artificial Eye Ointment (Posted by Tom Lamb at Drug Injury Watch) During February 2023 there were recalls of Global Pharma eye products, specifically: EzriCare…
-
Delsam Pharma’s Artificial Eye Ointment Recalled, Weeks After Artificial Tears Products Withdrawal
Updates About Bacterial Contamination Problem for These Over-The-Counter (OTC) Eye Products Given by FDA and CDC (Posted by Tom Lamb at Drug Injury Watch) On February 21, 2023, and February 22, 2023, there were updates…
-
Artificial Tears Eye Drops Recall Involving EzriCare and Delsam Pharma’s Products in February 2023
Serious Infections Causing Vision Loss Have Been Linked to the Use of EzriCare Artificial Tears Lubricant Eye Drops (Posted by Tom Lamb at Drug Injury Watch) Today we pick up where our article from last…
-
EzriCare Artificial Tears Associated With Eye Infections: February 2023 CDC Warnings Issued
CDC Recommends Patients Stop Using EzriCare Artificial Tears Products Pending Additional Guidance For These OTC Eye Drops (Posted by Tom Lamb at Drug Injury Watch) On February 1, 2023, the US Centers for Disease Control…